EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eberlein, U.
Right arrow Articles by Esperer, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eberlein, U.
Right arrow Articles by Esperer, H. D.

European Journal of Cardio-Thoracic Surgery, Vol 4, 605-612, Copyright © 1990 by European Association for Cardio-thoracic Surgery


ARTICLES

Thromboembolic and bleeding complications after mitral valve replacement

U Eberlein, J von der Emde, J Rein and HD Esperer
Department of Cardiac Surgery, University of Erlangen-Nurnberg, FRG.

One thousand six hundred and sixty-eight consecutive patients who underwent isolated mitral valve replacement (MVR) from 1963 to 1984 were evaluated retrospectively. Thromboembolism occurred with a linearised rate of 2.5% +/- 0.2%/patient-year (PY) for Starr-Edwards disc prosthesis Model 6520, 2.4% +/- 0.3%/PY for Bjork-Shiley plane prosthesis, 3.0% +/- 0.8%/PY for Bjork-Shiley convexo-concave 60 degrees prosthesis, 3.0% +/- 0.8%/PY for St. Jude Medical prosthesis and 3.4% +/- 0.5%/PY for Carpentier-Edwards tissue valve without the differences reaching significance. In the SJM group, the incidence of thromboembolism was significantly higher (P less than 0.025) in smaller sizes (less than M29) probably due to a more turbulent flow. The linearised rate for major haemorrhage was 1.6% +/- 0.1%/PY. Twenty- three percent of the thromboembolic and 18% of the bleeding events were fatal. Sixty-eight percent of the emboli involved the central nervous system and bleeding apart from fatalities was predominantly non- cerebral (81%). Whereas thromboembolism was a time-related event with more than twice as high a risk in the first postoperative year (4.2% +/- 0.5% vs. 1.7% +/- 0.8%, P less than 0.01), bleeding occurred with a constant rate over time (0.9% +/- 0.4%). Adequacy of anticoagulation was an important risk factor for postoperative embolism with the prothrombin time (PT) exceeding the therapeutic range in 65% of all events. A preoperative history of embolism was the only additional patient-related risk factor for postoperative embolism (18.3% vs. 9.6%, P less than 0.001). In 30% of all haemorrhage, the PT was below 15%.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
CirculationHome page
R. R. Moss, K. H. Humphries, M. Gao, C. R. Thompson, J. G. Abel, G. Fradet, and B. I. Munt
Outcome of Mitral Valve Repair or Replacement: A Comparison by Propensity Score Analysis
Circulation, September 9, 2003; 108(90101): II-90 - 97.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
R. A. Cesnjevar, R. Feyrer, F. Walther, F. O. Mahmoud, Y. Lindemann, and J. von der Emde
High-risk mitral valve replacement in severe pulmonary hypertension--30 years experience
Eur. J. Cardiothorac. Surg., April 1, 1999; 13(4): 344 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L-F. Debetaz, P. Ruchat, M. Hurni, A. Fischer, F. Stumpe, H. Sadeghi, G. van Melle, and J-J. Goy
ST. JUDE MEDICAL VALVE PROSTHESIS: AN ANALYSIS OF LONG-TERM OUTCOME AND PROGNOSTIC FACTORS
J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 134 - 148.
[Abstract] [Full Text]


Home page
NEJMHome page
M. H. Eckman, H. J. Levine, and S. G. Pauker
Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant Therapy
N. Engl. J. Med., September 2, 1993; 329(10): 696 - 702.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1990 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.